18 results
PRE 14A
GOSS
Gossamer Bio Inc
17 Apr 23
Preliminary proxy
4:01pm
, portfolio sustainability, business development and financial targets. The board of directors, upon recommendation of the compensation committee, determines … and parity in targets among executives in roles of a given level. For 2022, our compensation committee reviewed competitive market data prepared
8-K
EX-99.2
18xd7a9xz xgxop
14 May 19
Gossamer Bio Announces First Quarter 2019 Financial Results
7:31am
424B4
x6od3 8qx50mptfn
8 Feb 19
Prospectus supplement with pricing info
4:40pm
S-1/A
3z0tye67jz3 5dyhtjvs
23 Jan 19
IPO registration (amended)
4:39pm
S-1
oi9nesi
21 Dec 18
IPO registration
4:39pm
S-1
EX-10.9
jzdmwpwt57ortpt18
21 Dec 18
IPO registration
4:39pm
S-1
EX-10.1
xl02w3un yz
21 Dec 18
IPO registration
4:39pm
S-1
EX-10.8
ly7d0a
21 Dec 18
IPO registration
4:39pm
DRS/A
oyjmxoj40e 9c9o7j
29 Nov 18
Draft registration statement (amended)
12:00am
DRS
EX-10.8
h2p923umfnb3
11 Oct 18
Draft registration statement
12:00am
DRS
EX-10.1
9ct9m4
11 Oct 18
Draft registration statement
12:00am
DRS
gwqbgzivhdwtexi
11 Oct 18
Draft registration statement
12:00am
DRS
EX-10.9
5zsvtdd165fvqoc
11 Oct 18
Draft registration statement
12:00am
- Prev
- 1
- Next